Viewing Study NCT03322566

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search All Studies All Organizations Report Bug

Ignite Creation Date: 2025-12-24 @ 4:15 PM

Ignite Modification Date: 2025-12-24 @ 4:15 PM

Study NCT ID: NCT03322566

Status: COMPLETED

Last Update Posted: 2022-01-24

First Post: 2017-10-24

Is Possible Gene Therapy: False

Has Adverse Events: True

Brief Title: A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

Sponsor: Incyte Corporation

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module